| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Apr 23, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 5,000 | -- | -- |
| Apr 23, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | 10,210 | -- | -- |
| Sep 03, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
| Feb 15, 2024 |
CHIEF MEDICAL OFFICER
|
CHIEF MEDICAL OFFICER | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,081 | $1.27 | 31,487 |
| Sep 18, 2023 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 40,000 | -- | 40,000 |
| Feb 15, 2023 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 120,000 | -- | 124,794 |
| Sep 18, 2023 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 20,000 | -- | 144,794 |
| Apr 01, 2021 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 275,000 | -- | 275,000 |
| Sep 01, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 300,000 | -- | 300,000 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.